Key facts
- This page summarizes Mark D. Smith's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 May 2022, 16:20.
Mark D. Smith - 17 May 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)
- Reporting relationship
- Director
- Issuer ticker
- TDOC
- Reported as of
- 17 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 May 2022, 16:20:45 UTC
- Prior SEC filing
- 06 Dec 2021
- Next SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam C. Vandervoort, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark D. Smith filed Form 4 for Teladoc Health, Inc. (TDOC) on 18 May 2022.
Change
- Previous filing in this sequence was filed on 06 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +819
- Change %
- +23%
- Price
- Shares after
- 4,355
- Date
- 17 May 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -819
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 819
- Date
- 17 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 819
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
Footnote F3
On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.